Skip to content
2000
Volume 16, Issue 1
  • ISSN: 2212-7968
  • E-ISSN: 1872-3136

Abstract

Low-molecular-mass selenium (LMM-Se) molecules, such as ebselen and diphenyldiselenide, have many biological and potential therapeutic activities; however, little is known about their mechanism of action. It has been stipulated that LMM-Se can modify the physiological chemistry of endogenous thiol (–SH) and selenol (–SeH) groups by different mechanisms. Generically, LMM-Se compounds are poor mimetics of glutathione peroxidase (GPx) enzyme, suggesting that their thiol-modifier effect is more reasonable to justify their biological action. Unfortunately, the LMM-Se interactions with their targets are relatively non-specific. Here, the action of LMM-Se as potential therapeutic agents will be discussed, as well as the bottleneck and myths about their potential use as therapeutic agents.

Loading

Article metrics loading...

/content/journals/ccb/10.2174/2212796816666220422135204
2022-03-01
2025-12-05
Loading full text...

Full text loading...

/content/journals/ccb/10.2174/2212796816666220422135204
Loading

  • Article Type:
    Review Article
Keyword(s): antioxidant; diphenyldiselenide; Ebselen; mimetic; selenium; thiol-modifier
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test